| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
β-adrenoreceptors and the risk of Parkinson's disease
|
Hopfner, Franziska
|
|
|
19 |
3 |
p. 247-254
|
article
|
| 2 |
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study
|
Armangue, Thaís
|
|
|
19 |
3 |
p. 234-246
|
article
|
| 3 |
Breaking boundaries between demyelinating disorders and autoimmune encephalitis
|
Marignier, Romain
|
|
|
19 |
3 |
p. 199-200
|
article
|
| 4 |
Challenges to stroke care 5 years after endovascular therapy became the standard
|
Goyal, Mayank
|
|
|
19 |
3 |
p. 210-211
|
article
|
| 5 |
Correction to Lancet Neurol 2020; 19: 247–54
|
|
|
|
19 |
3 |
p. e3
|
article
|
| 6 |
Correction to Lancet Neurol 2020; 19: 38–48
|
|
|
|
19 |
3 |
p. e3
|
article
|
| 7 |
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
|
Chataway, Jeremy
|
|
|
19 |
3 |
p. 214-225
|
article
|
| 8 |
Encephalitis—spreading the word
|
Morgan, Jules
|
|
|
19 |
3 |
p. 213
|
article
|
| 9 |
Essential tremor-plus: a controversial new concept
|
Louis, Elan D
|
|
|
19 |
3 |
p. 266-270
|
article
|
| 10 |
Essential tremor-plus: a temporary label
|
Vidailhet, Marie
|
|
|
19 |
3 |
p. 202-203
|
article
|
| 11 |
Feast or famine in multiple sclerosis therapeutics
|
Fox, Robert J
|
|
|
19 |
3 |
p. 196-197
|
article
|
| 12 |
Health-care disparities for people with multiple sclerosis
|
Laurson-Doube, Joanna
|
|
|
19 |
3 |
p. 207-208
|
article
|
| 13 |
Issues important to the design of stroke recovery trials
|
Cramer, Steven C
|
|
|
19 |
3 |
p. 197-198
|
article
|
| 14 |
Leading the way for neuromuscular disorders since 1950
|
The Lancet Neurology,
|
|
|
19 |
3 |
p. 195
|
article
|
| 15 |
Osmotherapy in traumatic brain injury
|
Rowland, Matthew J
|
|
|
19 |
3 |
p. 208
|
article
|
| 16 |
Patient-reported outcome measures: the need for new and reliable tools
|
Khajuria, Ankur
|
|
|
19 |
3 |
p. 206-207
|
article
|
| 17 |
Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial
|
Chabriat, Hugues
|
|
|
19 |
3 |
p. 226-233
|
article
|
| 18 |
Subjective cognitive decline: what is it good for?
|
Howard, Robert
|
|
|
19 |
3 |
p. 203-204
|
article
|
| 19 |
The characterisation of subjective cognitive decline
|
Jessen, Frank
|
|
|
19 |
3 |
p. 271-278
|
article
|
| 20 |
The global burden of neurological disorders: translating evidence into policy
|
Feigin, Valery L
|
|
|
19 |
3 |
p. 255-265
|
article
|
| 21 |
The growing burden of neurological disorders in low-income and middle-income countries: priorities for policy making
|
Winkler, Andrea S
|
|
|
19 |
3 |
p. 200-202
|
article
|
| 22 |
The need for continued care after sponsor closure
|
May, Arne
|
|
|
19 |
3 |
p. 205
|
article
|
| 23 |
The need for continued care after sponsor closure – Authors' reply
|
Goadsby, Peter J
|
|
|
19 |
3 |
p. 205-206
|
article
|
| 24 |
The unique and specialised history of Queen Square
|
Koehler, Peter J
|
|
|
19 |
3 |
p. 212
|
article
|
| 25 |
William Jagust: Arrow Through The Rings
|
Burton, Adrian
|
|
|
19 |
3 |
p. 209
|
article
|
Journal description